ADPT vs REG · rev $179.0M vs P/E 34, $12.93B cap
Adaptive Biotechnologies Corp (ADPT) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported ADPT revenue for 2024-12-31 was $179.0M. Net income was -$159.6M. Revenue was up 5.1% from 2023-12-31 to 2024-12-31. ADPT currently screens at market cap $2.69B.
REG does not have a complete income-statement cache yet.
ADPT currently screens at market cap $2.69B. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the ADPT and REG stock pages for the full models.
Not investment advice.